$CTSO News Article - CytoSorbents Announces Independent Data Safety and Monitoring Board Recommends Completion of the Pivotal STAR-T Trial Without Modifications Following Second Scheduled Safety Review
https://marketwirenews.com/news-releases/cyto...05874.html